Description
AmbioPharm is a U.S.-based contract development and manufacturing organisation (CDMO) that specialises in peptide synthesis and pharmaceutical manufacturing.
Founded in 2004, AmbioPharm offers custom peptide manufacturing services, including solid-phase and liquid-phase peptide synthesis. The company operates from multiple facilities in the U.S. and China, supporting global pharmaceutical and biotechnology clients.
Key products and services:
- Custom peptide synthesis (solid-phase and liquid-phase)
- GMP peptide manufacturing
- Fragment-based peptide synthesis
- Peptide purification and isolation
- Full contract manufacturing services
AmbioPharm combines cutting-edge technology with a skilled workforce to meet the growing demand for therapeutic peptides and support the global pharmaceutical supply chain.
Contact Information
AI and Digital Manufacturing Benchmarking Survey
Take this quick 5 minute assessment to benchmark your organisation’s digital and AI maturity — and see how you compare with industry peers.